Hot Features
Premium
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Période:
Mode Dessin:
| Volume | 39 427 |
|
|||||
| Actualités | (1) |
| Nom Action | Symbole Action | Marché | Type |
|---|---|---|---|
| Estrella Immunopharma Inc | ESLAW | NASDAQ | Warrant |
| Variation Action | Variation Action% | Cours Dernier | Dernier échange
|
|
|---|---|---|---|---|
| -0,0001 | -0,12% | 0,08 | 22:02:00 |
| Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
|---|---|---|---|---|
| 0,08 | 0,0656 | 0,1047 | 0,08 | 0,0801 |
| Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne |
|---|---|---|---|---|
| 59 | 39 427 | 0,0982055 | 3 872 | - |
| Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
|---|---|---|---|---|
| 22:00:00 | 100 | 0,1019 | USD |
Bilan Comptable
| Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
|---|---|---|---|---|---|---|
| 2,91M | 36,38M | - | 0 | -7,31M | -0,20 | - |
| Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
plus d’informations financières »
Actualités Estrella Immunopharma
| Date | Heure | Source | Titre |
|---|---|---|---|
| 19/2/2025 | 22:46 | Business Wire | Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives.. |
| 14/2/2025 | 22:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 14/2/2025 | 22:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 23/12/2024 | 20:43 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 20/12/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 17/12/2024 | 22:59 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 16/12/2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/12/2024 | 23:08 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 09/12/2024 | 20:45 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 06/12/2024 | 15:12 | Edgar (US Regulatory) | Form 8-K - Current report |
| 27/11/2024 | 14:45 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 26/11/2024 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Estrella Immunopharma
Aucune Discussion TrouvéeAjouter une Discussion
Historiques
| Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
|---|---|---|---|---|---|---|---|
| 1 semaine | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 mois | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 an | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 ans | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 ans | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:ESLAW -
What is the current Estrella Immunopharma Inc share price?
The current share price of Estrella Immunopharma Inc is US$ 0,08
How many Estrella Immunopharma Inc shares are in issue?
Estrella Immunopharma Inc has 36 376 000 shares in issue
What is the market cap of Estrella Immunopharma Inc?
The market capitalisation of Estrella Immunopharma Inc is USD 2,91M
What is the 1 year trading range for Estrella Immunopharma Inc share price?
Estrella Immunopharma Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Estrella Immunopharma Inc?
The price to earnings ratio of Estrella Immunopharma Inc is -6,82
What is the reporting currency for Estrella Immunopharma Inc?
Estrella Immunopharma Inc reports financial results in USD
What is the latest annual profit for Estrella Immunopharma Inc?
The latest annual profit of Estrella Immunopharma Inc is USD -7,31M
What is the registered address of Estrella Immunopharma Inc?
The registered address for Estrella Immunopharma Inc is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
Which industry sector does Estrella Immunopharma Inc operate in?
Estrella Immunopharma Inc operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
